Recurrence of papillary thyroid cancer: a systematic appraisal of risk factors
HR Nieto, CEM Thornton, K Brookes… - The Journal of …, 2022 - academic.oup.com
Context Thyroid cancer recurrence is associated with increased mortality and adverse
outcomes. Recurrence risk is currently predicted using clinical tools, often restaging patients …
outcomes. Recurrence risk is currently predicted using clinical tools, often restaging patients …
Recurrence-associated genes in papillary thyroid cancer: An analysis of data from The Cancer Genome Atlas
MN Chien, PS Yang, JJ Lee, TY Wang, YC Hsu… - Surgery, 2017 - Elsevier
Background Recurrence of papillary thyroid cancer is not uncommon, but incorporating
clinicopathologic parameters to predict recurrence is suboptimal. The aim of this study was …
clinicopathologic parameters to predict recurrence is suboptimal. The aim of this study was …
A novel RNA sequencing-based risk score model to predict papillary thyroid carcinoma recurrence
J He, Z Tian, X Yao, B Yao, Y Liu, J Yang - Clinical & Experimental …, 2020 - Springer
The papillary thyroid carcinoma (PTC) usually shows an excellent prognosis. But some
patients suffer recurrence after treatment. Recent progress in RNA sequencing (RNA-Seq) …
patients suffer recurrence after treatment. Recent progress in RNA sequencing (RNA-Seq) …
Mapping the molecular basis and markers of papillary thyroid carcinoma progression and metastasis using global transcriptome and microRNA profiling
Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer (TC). In a
subgroup of patients with PTC, the disease progresses to an invasive stage or in some …
subgroup of patients with PTC, the disease progresses to an invasive stage or in some …
Comprehensive transcriptomic analysis of papillary thyroid cancer: potential biomarkers associated with tumor progression
Purpose Identification of stage-specific prognostic/predictive biomarkers in papillary thyroid
carcinoma (PTC) could lead to its more efficient clinical management. The main objective of …
carcinoma (PTC) could lead to its more efficient clinical management. The main objective of …
Development of a risk scoring system for patients with papillary thyroid cancer
As the importance of personalized therapeutics in aggressive papillary thyroid cancer (PTC)
increases, accurate risk stratification is required. To develop a novel prognostic scoring …
increases, accurate risk stratification is required. To develop a novel prognostic scoring …
[HTML][HTML] Screening and validation of lymph node metastasis risk-factor genes in papillary thyroid carcinoma
Q Zhang, J Li, H Shen, X Bai, T Zhang… - Frontiers in …, 2022 - frontiersin.org
Background Although most papillary thyroid carcinoma (PTC) cases have a good prognosis,
some PTCs are more aggressive and are often accompanied by lymph node (LN) …
some PTCs are more aggressive and are often accompanied by lymph node (LN) …
[HTML][HTML] A novel integrative risk index of papillary thyroid cancer progression combining genomic alterations and clinical factors
Although the majority of papillary thyroid cancer (PTC) is indolent, a subset of PTC behaves
aggressively despite the best available treatment. A major clinical challenge is to reliably …
aggressively despite the best available treatment. A major clinical challenge is to reliably …
[HTML][HTML] Development of prognostic signatures for intermediate-risk papillary thyroid cancer
Abstract Background The incidence of Papillary thyroid carcinoma (PTC), the most common
type of thyroid malignancy, has risen rapidly worldwide. PTC usually has an excellent …
type of thyroid malignancy, has risen rapidly worldwide. PTC usually has an excellent …
A novel gene panel for prediction of lymph-node metastasis and recurrence in patients with thyroid cancer
EML Ruiz, T Niu, M Zerfaoui, M Kunnimalaiyaan… - Surgery, 2020 - Elsevier
Background Although well-differentiated papillary thyroid cancer may remain indolent,
lymph node metastases and the recurrence rates are approximately 50% and 20 …
lymph node metastases and the recurrence rates are approximately 50% and 20 …
相关搜索
- thyroid carcinoma risk factor
- genes in papillary thyroid cancer
- patients with papillary thyroid cancer
- papillary thyroid carcinoma progression
- thyroid cancer systematic appraisal
- thyroid cancer prognostic signatures
- thyroid cancer lymph node
- risk score tumor progression
- thyroid carcinoma screening and validation
- risk score iodine ablation
- risk score matched analysis
- clinical factors risk index
- gene panel recurrence in patients
- iodine ablation tumor progression
- matched analysis tumor progression
- clinical factors genomic alterations